In summary, the LDL-C/Apo B ratio was closely associated with the risk of DKD, and a lower LDL-C/Apo B ratio might be a potent risk factor and therapeutic target for prevention and treatment of DKD in patients with T2D. Here, APOB is linked to diabetic kidney disease.